Renal effects of antituberculous antibiotics.
D000284:Administration, Oral; D000469:Alkaline Phosphatase / Q000652:urine; D000818:Animals; D000995:Antitubercular Agents / Q000494:pharmacology*; D001835:Body Weight; D004977:Ethambutol / Q000494:pharmacology*; D005260:Female; D007274:Injections, Intraperitoneal; D007612:Kanamycin / Q000494:pharmacology; D007668:Kidney / Q000187:drug effects* / Q000201:enzymology; D007770:L-Lactate Dehydrogenase / Q000652:urine; D007931:Leucyl Aminopeptidase / Q000652:urine; D008297:Male; D051381:Rats; D012293:Rifampin / Q000494:pharmacology*; D013307:Streptomycin / Q000494:pharmacology
D000995:Antitubercular Agents; D007612:Kanamycin; D004977:Ethambutol; D007770:L-Lactate Dehydrogenase; D000469:Alkaline Phosphatase; D007931:Leucyl Aminopeptidase; D012293:Rifampin; D013307:Streptomycin